In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist

In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist

Solid rationales are still present for the identification of synthetic ligands to simultaneously target multiple PPAR subtypes for the treatment of T2DM. The purpose of this study was to characterize the in vitro and in vivo differential effects of chiglitazar, a non-TZD type of PPAR pan-agonist cur...

Full description

Bibliographic Details
Main Authors: B. K. He, Z. Q. Ning, Z. B. Li, S. Shan, D. S. Pan, B. C. B. Ko, P. P. Li, Z. F. Shen, G. F. Dou, B. L. Zhang, X. P. Lu, Y. Gao
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2012/546548

Internet

http://dx.doi.org/10.1155/2012/546548

Similar Items